Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists

Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists

US Patent 9914720 · Granted Mar 13, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridin-3-yl derivatives2025
Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their 2025
Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their 2025
Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan2025
Crystalline forms2025
N-substituted indole derivatives as PGE2 receptor modulators2024
Pyrimidine derivatives as PGE2 receptor modulators2023
Pyrimidine derivatives as PGE2 receptor modulators2023
Phenyl derivatives as PGE2 receptor modulators2023
Phenyl derivatives as PGE2 receptor modulators2023
Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan2023
Crystalline form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3-yl]-2- [4-(12023